Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study
- 31 July 2000
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 78 (1) , 52-57
- https://doi.org/10.1006/gyno.2000.5827
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Endometrial CarcinomaNew England Journal of Medicine, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions.Journal of Clinical Oncology, 1991
- The calculation of received dose intensity.Journal of Clinical Oncology, 1990
- Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group studyGynecologic Oncology, 1989
- Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimatorsComputer Methods and Programs in Biomedicine, 1988
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958